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Summary
The biosynthetic gene cluster for the enediyne antitu-
mor antibiotic neocarzinostatin (NCS) was localized
to 130 kb continuous DNA from Streptomyces carzi-
nostaticus ATCC15944 and confirmed by gene inacti-
vation. DNA sequence analysis of 92 kb of the cloned
region revealed 68 open reading frames (ORFs), 47 of
which were determined to constitute the NCS cluster.
Sequence analysis of the genes within the NCS cluster
suggested dNDP-D-mannose as a precursor for the
deoxy aminosugar, revealed two distinct type I polyke-
tide synthases (PKSs), and supported a convergent
model for NCS chromophore biosynthesis from the
deoxy aminosugar, naphthoic acid, and enediyne
core building blocks. These findings shed light into
deoxysugar biosynthesis, further support the itera-
tive type I PKS paradigm for enediyne core biosynthe-
sis, and unveil a mechanism for microbial polycyclic
aromatic polyketide biosynthesis by an iterative type
I PKS.
Introduction
The enediynes are a class of natural products that con-
sist of a unique molecular architecture and exhibit phe-
nomenal antitumor activity [1–4]. They are structurally
characterized by an enediyne core containing two acet-
ylenic groups conjugated to a double bond or incipient
double bond within a 9-membered ring, such as neocarzi-
nostatin (NCS) and C-1027, or a 10-membered ring, such
as calicheamicin (CAL) (Figure 1). The enediyne cores are
further decorated with a variety of peripheral moieties,
and the 9-membered ring enediynes, also known as
chromoproteins, are noncovalently associated with an
apo-protein that has been proposed to dually stabilize
and transport the bioactive chromophore.
As a family, the enediynes share a common mecha-*Correspondence: bshen@pharmacy.wisc.edunism of action: the chromophore undergoes electronic
rearrangement to form a diradical species, which sub-
sequently can abstract hydrogen atoms from the de-
oxyribose of DNA leading to single- and double-
stranded DNA lesions [3, 4]. A thiol is required to acti-
vate radical formation, although a few enediynes have
been reported to form diradicals in a thiol-independent
manner, likely the result of the inherent instability of the
9-membered ring enediyne core. The ability of the enedi-
ynes to ultimately cleave DNA has attracted great inter-
est in developing these compounds into anticancer
drugs. A CD33 mAB-CAL conjugate (Mylotarg) was ap-
proved in the US to treat acute myeloid leukemia in
2000 [5]. A poly(styrene-co-maleic acid)-NCS conjugate
(SMANCS) was approved in Japan and has been mar-
keted for use against hepatoma since 1994 [2]. Several
antiheptoma mAB-C-1027 conjugates have displayed
high tumor specificity and exerted a strong inhibitory
effect on the growth of established tumor xenografts
[6]. In general, however, the high cell toxicity of the ene-
diynes has limited their clinical utility, and ways of har-
nessing the potent activity of the enediynes for antican-
cer drug development is currently an ongoing area of
intense research [1–6].
NCS, produced by Streptomyces carzinostaticus
ATCC 15944, was the first member of the enediyne fam-
ily to be structurally elucidated [7]. Consequently, NCS
has been widely used as a model for the enediynes to
investigate the molecular details of chromophore acti-
vation and DNA binding and cleavage [1–3]. The struc-
ture of the NCS chromoprotein has been solved by 1H
and 13C NMR spectroscopy [8, 9] and X-ray crystallog-
raphy [2]. NCS chromophore-DNA complexes have also
been well studied, revealing multiple modes of DNA re-
cognition and binding [10].
Biosynthetic studies on the enediyne family have
been limited primarily by their extreme instability and
low production in fermentation, rendering it difficult to
carry out in vivo feeding experiments [4, 11]. In spite of
the difficulties, the enediyne cores of NCS [12], dynemi-
cin [13], and esperamicin [14] were established to origi-
nate from a minimum of eight head-to-tail acetate units,
but it was unclear until recently whether this assembly
occurred by polyketide biosynthesis or degradation of
a fatty acid precursor. The recent cloning, sequencing,
and characterization of the C-1027 [15] and CAL [16]
biosynthetic gene clusters revealed a single enediyne
polyketide synthase (PKS) gene, establishing a polyke-
tide paradigm for enediyne biosynthesis [7–19]. Also
found within the C-1027 gene cluster were cagA, en-
coding the C-1027 apo-protein, and the biosynthetic
machinery for the peripheral moieties, suggesting a
convergent strategy for chromoprotein enediyne bio-
synthesis [15].
We proposed that NCS is biosynthesized in a similar
fashion as C-1027 on the basis that NCS and C-1027
share a similar enediyne core, a 6-deoxysugar moiety,
and an apo-protein, and therefore adopted the same
strategy as that for C-1027 to clone the NCS biosyn-
thetic gene cluster. Here we report the cloning and
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S. carzinostaticus ATCC15944, the sequence of the
complete NCS gene cluster, determination of the clus-
ter boundaries, and functional assignments of the gene
products. On the basis of these results, we propose a
convergent model for NCS chromophore biosynthesis
from the deoxy aminosugar, naphthoic acid, and enedi-
yne core building blocks. The NCS cluster is charac-
terized with two distinct type I PKSs, NcsE for the ene-
diyne core and NcsB for the naphthoic acid moiety, and
a deoxysugar biosynthetic pathway most likely starting
from dNDP-D-mannose. These findings further support
the iterative type I PKS paradigm for enediyne core bio-
synthesis [15–19], unveil a novel mechanism for micro-
bial polycyclic aromatic polyketide biosynthesis by an
iterative type I PKS [19, 20], and shed new light into
deoxysugar biosynthesis. The NCS cluster, together
with the growing list of other enediyne biosynthetic
gene clusters [15–18], provides a unique opportunity to
investigate the molecular basis of enediyne biosynthe-
sis by a comparative genomics approach.
F
Results and Discussion m
Identification, Localization, and Cloning of the ncs r
Gene Cluster from S. carzinostaticus ATCC15944 s
Deoxysugars are frequently found in secondary metab- f
olites and are vital components for the efficacy and r
specificity of a natural product's biological activity. The 2
biosynthetic pathways of these unusual sugars have f
been extensively investigated. The first committed step r
of the biosynthesis of all deoxyhexoses is through the t
intermediate dNDP-4-keto-6-deoxyhexose, a reaction q
catalyzed by an NAD+-dependent oxidoreductase from p
the precursor dNDP-D-hexose (most commonly dNDP- o
D-glucose, and hence the name of NGDH derived from b
dNDP-D-glucose 4,6-dehydratase) [21]. We have pre-
viously taken advantage of the highly conserved nature i
of NGDHs and used degenerate primers [22] to amplify g
the NGDH gene sgcA by PCR from S. globisporus, and w
this locus was used as a starting point for chromo- t
somal walking leading to the eventual localization of n
the entire C-1027 biosynthetic gene cluster [15, 23]. O
NCS contains a similar 6-deoxyhexose to C-1027, and d
as a result, we adopted the same strategy to identify t
the ncs gene cluster. A distinct product with the pre- (
dicted size of 550 bp was amplified by PCR and con- t
firmed to be a putative NGDH gene, serving as the first b
probe (Figure S1A). c
The cloning of the genes necessary for C-1027 bio- s
synthesis revealed that cagA, encoding the C-1027 f
apo-protein, was within the boundaries of the gene c
cluster [15]. Therefore, the gene for the NCS apo-pro- (
tein, ncsA, was used as the second probe. The primary c
sequence for ncsA has previously been established [re- k
viewed in 11], and PCR with primers designed accord- m
ing to the known sequence yielded a distinct product p
with the predicted size of 590 bp. The PCR product was p
cloned into pGEM-T to yield pBS5024, confirmed by
DNA sequencing, and utilized as the second probe. S
The digoxigenin-(DIG)-labeled NGDH and ncsA o
probes were both used to screen approximately 4800 T
pclones of the genomic library. While the NGDH probeesulted in the isolation of four overlapping cosmids
panning 67 kb (Figure S1B), the ncsA probe afforded
ourteen overlapping cosmids spanning 64 kb, as rep-
esented by pBS5002, pBS5003, and pBS5004 (Figure
A). However, the two loci do not overlap. Since genes
or antibiotic production are known to cluster in one
egion of the chromosome in Streptomyces, we set out
o first determine if the putative NGDH locus was re-
uired for NCS biosynthesis by gene disruption. Sur-
risingly, inactivation of the NGDH gene has no effect
n NCS production, excluding its involvement in NCS
iosynthesis (Figure S1C).
We next turned our attention to the ncsA locus. Since
t was proposed that ncsA should reside within the NCS
ene cluster, a 7.5 kb BglII fragment containing ncsA
as cloned from pBS5004. DNA sequence analysis of
his fragment revealed six complete ORFs (including
csA) and one incomplete ORF. Remarkably, the four
RFs encode a dNDP-D-mannose synthase (NcsC),
NDP-hexose 4,6-dehydratase (NcsC1, a second dis-
inct NGDH gene in this organism), N-methyltransferase
NcsC5), and glycosyltransferase (NcsC6). These are
he enzymes that would be predicted to be essential for
iosynthesis of the deoxy aminosugar moiety of NCS
hromophore (Figure 3A), indicating that the NCS bio-
ynthetic locus was identified. To ensure that we have
ull coverage of the entire NCS gene cluster, additional
hromosomal walking from the left end of pBS5002
probe 3) and the right end of pBS5004 (probe 4) was
arried out, leading to the eventual localization of a 130
b continuous DNA region covered by overlapping cos-
ids as exemplified by pBS5002, pBS5003, pBS5004,
BS5005, pBS5007, pBS5010, pBS5013, pBS5015, and
BS5017 (Figure 2A).
equencing and Organization
f the ncs Gene Cluster
hree representative overlapping cosmids, pBS5002,
BS5004, and pBS5017 were selected for DNA se-igure 1. Structures of Neocarzinostatin (NCS) and C-1027 Chro-
ophores and Calicheamicin (CAL) γ1I
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295Figure 2. S. carzinostaticus ATCC15944 as Represented by Nine Cosmid Clones and Restriction Map and Genetic Organization of the ncs
Biosynthetic Gene Cluster
(A) A 140 kb locus from S. carzinostaticus ATCC15944 as represented by nine cosmid clones. Solid black bars indicate regions whose
sequence has been determined (AY117439).
(B) Restriction map and genetic organization of the ncs biosynthetic gene cluster. Proposed functions for individual orfs are shade-coded
and summarized in Table 1.quencing by a shotgun method, revealing 68 ORFs (Fig-
ure 2B). The overall GC content of the sequenced re-
gion was 68.88%, slightly lower than the characteristic
w75% for Streptomyces DNA [22]. The sequence was
analyzed by comparison to database sequences, and
functional assignments to individual ORFs are depos-
ited in the GenBank under accession number AY117439
and summarized in Table 1. Consistent with the struc-
ture of NCS, those identified within the ncs cluster in-
clude fourteen genes encoding the enediyne core bio-
synthesis, seven genes encoding deoxy aminosugar
biosynthesis, four genes encoding naphthoic acid bio-
synthesis (Figure 3), as well as seven ORFs encoding
putative regulation proteins (NcsR1 to NcsR7), two
ORFs encoding resistance proteins (NcsA and NcsA1),
and twelve ORFs whose functions could not be pre-
dicted or assigned on the basis of sequence analysis
(ORFs 13, 14, 19, 24, 27, 29, 32, 34, 49, 55, 56, and 57)
(Figure 2B).
ncs Cluster Boundaries
To determine the boundaries of the ncs cluster, orf6 and
ncsR1 were inactivated by gene disruption, and the re-
sultant mutant strains SB5004 (Dorf6) (Figures 4A and
4B) and SB5005 (DncsR1) (Figures 4C and 4D) were
confirmed by Southern analysis. orf6 encodes a puta-
tive membrane protein, and the Dorf6 mutant strain
SB5004 retained its NCS productivity similar to the
wild-type strain based on bioassay (Figure 4E, lane 2
versus lane 1), suggesting that it is outside of the ncs
cluster. In contrast, ncsR1 encodes a putative γ-butyro-lactone biosynthesis enzyme, and the DncsR1 mutant
strain SB5005 completely lost its ability to produce
NCS, confirming that ncsR1 is essential for NCS pro-
duction (Figure 4E, lane 3 versus lane 1). These results,
together with the functional assignment of NCS gene
products based on primary sequence analysis (Table
1), as well as organizational comparisons to the gene
cluster for C-1027 [23], support the conclusion that the
ncs cluster is minimally contained within the region
from ncsC4 to orf57, which consists of a total of 47
ORFs spanning 63 kb (Figure 2B). The availability of
genes within the cluster boundaries provides a basis to
propose the NCS biosynthetic pathway.
Biosynthesis of the Deoxy Aminosugar Moiety
Seven genes, ncsC to ncsC6, encode proteins that are
homologous to enzymes involved in deoxysugar biosyn-
thesis (Table 1), and accordingly, the biosynthesis of the
deoxy aminosugar moiety is proposed as outlined in Fig-
ure 3A. The deduced product of ncsC resembles a fam-
ily of dNDP-D-mannose synthases, suggesting the deoxy
aminosugar moiety is derived from D-mannose-1-phos-
phate. After dNDP-activation of mannose, NcsC1, ho-
mologous to the NGDH family of enzymes, catalyzes
the formation of dNDP-4-keto-6-deoxyhexose. NcsC2,
which is similar to dNDP-hexose dehydratases, cata-
lyzes the 2,3 dehydration of dNDP-hexose derivative to
form an α,β-unsaturated-4-ketosugar. NcsC3, similar to
a variety of histidine or phenylalanine ammonia lyases
and the aminomutase SgcC4 in C-1027 biosynthesis,
incorporates an amino group at C-2. NcsC4, a putative
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(A) Deoxy aminosugar; (B) naphthoic acid; (C) the enediyne core and a model for convergent assembly from the three building blocks.
D-Man-P, D-mannose-1-phosphate; D-Glu-P, D-glucose-1-phosphate; “NH3,” a yet to be established amino donor; and HMNA, 2-hydroxy-5-
methoxy-1-naphthoic acid.dNDP-hexose 4-ketoreductase, epimerizes the hydroxyl c
fgroup at C-4 by reduction of dNDP-2-amino-4-keto-
6-deoxyhexose. NcsC5, related to various N-methyl- p
gtransferases in deoxy aminosugar biosynthesis, meth-
ylates the primary amine (Figure 3A, path a). The final
igene product, NcsC6, encoding a putative glycosyl
transferase, is responsible for transferring the deoxy f
raminosugar moiety to the enediyne core (Figure 3C).
We have proposed, on the basis of sequence homol- m
logy of NcsC to dNDP-D-mannose synthases, that bio-
synthesis of the sugar moiety begins with dNDP-D-man- a
enose. This is unusual, since most of the deoxysugar
biosynthetic pathways characterized to date for second- d
iary metabolites start from dNDP-D-glucose [21]. We are
aware of only three examples in Streptomyces in which n
sdNDP-D-mannose was implicated as the precursor for
deoxysugar biosynthesis [24–26]. Since the C-2 hy- n
hdroxyl group is ultimately eliminated in the deoxy
aminosugar moiety of NCS, it cannot be excluded that a
sthe synthesis begins with D-glucose-1-phosphate and
that NcsC is instead a dNDP-D-glucose synthase (Fig- a
fure 3A, path b). However it is evident upon sequence
alignment that the C-terminal region of NcsC1 has low
sequence homology to other known NGDHs (Figure B
FS1A). The latter not only explains our inability to amplify
NcsC1 by the PCR method using primers designed ac-ording to dNDP-glucose 4,6-dehydratase enzymes
rom Streptomyces [22, 23], but also agrees with the
roposal that dNDP-D-mannose, instead of dNDP-D-
lucose, is the most likely substrate for NcsC1.
The amino transferase reaction catalyzed by NcsC3
s supported by our recent characterization of SgcC4
or C-1027 biosynthesis [27, 28]. SgcC4, although clearly
elated to ammonia lyases, was shown to be an amino-
utase with preferred intramolecular amino transfer fol-
owing the formation of an α,β-unsaturated carboxylic
cid intermediate; however, the Michael addition of an
xogenous amino group to this intermediate was also
etected [28]. The latter activity is reminiscent to what
s proposed for NcsC3. Furthermore, histidine and phe-
ylalanine lyases contain a critical serine in a highly con-
erved A-S-G motif that is used to form the 4-methylide-
eimidazole-5-one prosthetic group. While exhibiting
igh overall amino acid sequence homology to SgcC4
nd other ammonia lyases, NcsC3 lacks the conserved
erine residue, hence cannot be functional as a lyase,
fact that is consistent with NcsC3 as an aminotrans-
erase.
iosynthesis of the Naphthoic Acid Moiety
our genes, ncsB, ncsB1, ncsB2, and ncsB3 were iden-tified whose deduced functions (Table 1) would support
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297Table 1. Deduced Functions of ORFs in the ncs Biosynthetic Gene Cluster
Gene Sizea Protein Homologb Proposed Function
orf1-10 ORFs that are beyond the ncs cluster boundary
ncsC4 265 DnmV (AAB63047) dNDP-hexose 4-ketoreductase
ncsC3 526 HAL (BAB61863) Ammonia lyase/transferase
orf13 226 No Unknown protein
orf14 347 SgcM (AAL06686) Unknown protein
ncsB1 332 DnrK (Q06528) O-methyl transferase
orf16 144 SgcJ (AAL06676) Unknown protein
ncsB 1753 AviM (AF333038) Type I PKS: KS, AT, KR, DH, ACP
ncsB2 558 DhbE (AAN15214) CoA ligase
orf19 720 SCO4023 (NP_628205) Membrane protein
ncsC 234 GMPPB (NP_037466) dNDP-mannose synthase
ncsC1 331 PrmE (AAF82605) dNDP-hexose 4, 6-dehydratase
ncsC5 239 TxtB (AAG27088) N-methyltransferase
ncsC6 402 DPM1 (AAC98796) Glycosyltransferase
orf24 297 CelG (NP_460283) Glucosidase
ncsA 147 CagA (Q06110) Apo-protein
ncsF1 385 EPHX (AAA52389) Epoxide hydrolase
orf27 256 EtbD2 (BAA31164) Esterase/hydrolase
ncsB3 410 Cyp154c1 (1GWIA) P-450 hydroxylase
orf29 123 DnrV (AAD04716) Hydroxylase
ncsA1 494 PUR8 (P42670) Efflux pump transporter
ncsR4 205 Reut6225 (ZP_00027188) TetR/AcrR family, trancriptional regulator
orf32 458 CKX1 (Q9T0N8) Flavin-dependent oxidoreductase
ncsF2 387 EPH1 (AAF64646) Epoxide hydrolase
orf34 441 ERG1 (AAD10823) Oxygenase/Hydroxylase
ncsE11 267 SgcE11 (AAL06691) Unknown protein
ncsE9 552 ChoD (S72824) FDA-dependent oxidoreductase
ncsE8 199 SgcE8 (AAL06694) Unknown rpotein
ncsR6 354 KasT (BAC53615) StrR-like transcriptional regulator
ncsR5 264 GapR (AAA91363) AraC family, transcriptional regulator
ncsE7 450 Cyp4b1 (NP_058695) P-450 hydroxylase
ncsE6 182 MocB (BAD08312) Flavin-dependent oxidoreductase
ncsE10 153 SgcE10 (AAL06692) Thioesterase
ncsE 1977 SgcE (AAL06699) Type I PKS: KS, AT, (ACP), DH, KR, TD
ncsE5 364 SgcE5 (AAL06700) Unknown protein
ncsE4 636 SgcE4 (AAL06701) Unknown protein
ncsE3 328 CalU15 (AAM70330) Unknown protein
ncsE2 326 CalU15 (AAM70330) Unknown protein
ncsE1 147 StgR (CAA07076) Transcription regulator
orf49 400 OrfB (AAL06579) Transposase
ncsR7 392 AcyB2 (JC2032) SgcR3 like transcriptional regulator
ncsR3 206 JadR2 (AAB36583) γ-Butyrolactone receptor protein
ncsC2 326 JadV (AAL14256) dNDP-hexose dehydratase
ncsR2 208 VbrA (A57507) γ-Butyrolactone receptor protein
ncsR1 317 BarX (BAA23611) γ-Butyrolactone biosynthesis enzyme
orf55 264 No Unknown protein
orf5 324 CalU6 (AAM94767) Unknown protein
6orf57 167 SCP1.261c (NP_639871) Secreted protein
orf58-68 ORFs that are beyond the ncs cluster boundary
aNumbers are in amino acids.
bGiven in brackets are NCBI accession numbers.their involvement in the biosynthesis of the naphthoic
acid moiety of NCS as outlined in Figure 3B. Previous
biosynthetic studies on the naphthoic acid moiety re-
vealed that the C12 naphthoic ring is derived from a
hexaketide by six head-to-tail condensations of ace-
tate, and the O-methyl group is derived from S-adeno-
syl-L-methionine (AdoMet) [12]. While the current para-
digm for the biosynthesis of an aromatic polyketide
such as the naphthoic acid moiety in bacteria calls for
an iterative type II PKS [19], no candidate genes encod-
ing type II PKS could be found within the NCS cluster.
Instead, the NCS gene cluster contained two type I
PKSs, NcsE and NcsB. NcsE is clearly related to CalE8
[16] and SgcE [15], the PKSs responsible for the bio-
synthesis of the enediyne core. NcsB, in contrast,shows head-to-tail homology (excluding the ketoreduc-
tase [KR] domain) to AviM [29] and CalO5 [16], both of
which are iterative type I PKSs proposed to catalyze
the biosynthesis of an orsellinic acid moiety for avila-
mycin in S. viridochromogenes and CAL in Micromo-
nospora echinospora, respectively (Figure 5A).
NcsB consists of characteristic domains for type I
PKS, including a ketosynthase (KS), acyltransferase
(AT), dehydratase (DH), KR, and acyl carrier protein
(ACP). It catalyzes the formation of a nascent linear
hexaketide from one acetyl coenzyme A (CoA) and five
malonyl CoAs by iterative decarboxylative condensa-
tions with selective keto-reduction at C-5 and C-9 (the
timing of the keto-reduction steps is unknown), and the
resulting hexaketide intermediate then undergoes an
Chemistry & Biology
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Cluster Boundaries by Gene Disruption of
orf6 and ncsR1
(A) Construction of the orf6 gene disruption
vector pBS5021 and restriction maps of the
S. carzinostaticus ATCC15944 wild-type and
SB5004 mutant strains showing predicted
fragment sizes upon SmaI digestion. S,
SmaI.
(B) Southern analysis of wild-type (lane 1)
and SB5004 (lane 2) genomic DNAs digested
with SmaI by using the 0.80 kb internal frag-
ment of orf6 as a probe.
(C) Construction of the ncsR1 gene disrup-
tion vector pBS5022 and restriction maps of
the S. carzinostaticus ATCC15944 wild-type
and SB5005 mutant strains showing pre-
dicted fragment sizes upon SmaI digestion.
S, SmaI.
(D) Southern analysis of wild-type (lane 1)
and SB5004 (lane 2) genomic DNAs digested
with SmaI by using the 0.96 kb internal frag-
ment of ncsR1 as a probe.
(E) Determination of NCS production by as-
saying its antibacterial activity against M. lu-
teus. Lane 1, wild-type; lane 2, SB5004; lane
3, SB5005.intramolecular aldol condensation to furnish the naph- e
tthoic acid structure. Subsequent hydroxylation at C-7
followed by O-methylation affords the fully modified d
wnaphthoic acid moiety, and NcsB3, a homolog of the
P-450 family of hydroxylases, and NcsB1, a member p
tof the AdoMet-dependent methyltransferase family of
enzymes, serve as candidates for these two steps (Fig-
ure 3B). It remains to be established if the free naph- B
Athoic acid or the naphthoyl-S-NcsB is the preferred
substrate for NcsB3 and NcsB1. Should the latter be n
dthe case, ncsB2, located just upstream of ncsB, en-
codes a putative CoA ligase, serves as a candidate to i
Fcatalyze the attachment of naphthoyl moiety from naph-
thoyl-S-NcsB to the enediyne core (Figure 3C). The pro- t
dposed activity of NcsB2 would resemble the catalysis
performed by CoA ligases during the synthesis of CoA t
hester from carboxylic acid but in the reverse direction
in the presence of a donor hydroxyl group. C
wUntil recently, aromatic polyketides in bacteria were
believed to be biosynthesized solely by type II PKSs o
s[19]. Therefore, early attempts to clone the NCS gene
cluster utilized type II PKS genes as probes, and the a
mfinding of NcsB as a type I PKS explained why these
experiments failed. Currently, NcsB represents a third b
eexample of an iterative type I PKS for the biosynthesis
of an aromatic polyketide, and is the first to our knowl-dge to extend this emerging paradigm from monocylic
o include polycyclic aromatic compounds. This has in-
eed been confirmed recently by Sohng and coworkers
ho isolated 2-hydroxy-5-methyl-1-naphthoic acid, the
redicted product of NcsB, upon expression of ncsB in
wo Streptomyces hosts [20].
iosynthesis of the Enediyne Core
t least fourteen genes, ncsE to ncsE11 and ncsF1 to
csF2, could be identified within the ncs cluster, the
educed functions of which would support their roles
n the NCS enediyne core biosynthesis as outlined in
igure 3C. The enediyne core was previously predicted
o be synthesized by an iterative type I PKS with five
omains, of which the KS, AT, KR, and DH are charac-
eristic of known type I PKSs [15–19]. NcsE shows
ead-to-tail sequence homology to the SgcE [15] and
alE8 [16] enediyne PKSs (Figure 5B). Consequently,
e propose that NcsE, in a mechanistic analogy to
ther enediyne PKSs, catalyzes the formation of the na-
cent linear polyunsaturated intermediate from one
cetyl CoA and seven malonyl CoAs in an iterative
anner, which is processed to form the enediyne core
y several gene products, including NcsE1–E11 and
poxide hydrolases F1 and F2 (Figure 3C).
To confirm the essential role of NcsE in NCS biosyn-
Neocarzinostatin Biosynthetic Gene Cluster
299Figure 5. Domain Organization and Comparison of NcsB with the
AviM and CalO5 Orsellinic Acis Synthases and NcsE with the SgcE
and CalE8 Enediyne PKSs
(A) shows comparison of NcsB with the AviM and CalO5 orsellinic
acis synthases and (B) shows a comparison of NcsE with the SgcE
and CalE8 enediyne PKSs. aa, amino acid; KS, ketosynthase; AT,
acyltransferase; ACP, acyl carrier protein; KR, ketoreductase; DH,
dehydratase; TD, terminal domain (possibly containing a phospho-
pantetheinyl transferase).thesis, an internal fragment of NcsE containing a por-
tion of the AT domain, the entire ACP, and a portion of
the KR domain, was replaced by the ermE resistance
gene. The resultant pBS5019 that contains a mutated
version of ncsE was introduced into S. carzinostaticus
chromosome by homologous recombination to gener-
ate the ncsE:ermE mutant strain SB5002, whose geno-
type was confirmed by Southern analysis (Figures 6A
and 6B). SB5002 completely lost the ability to produce
NCS, as would be expected for an essential enzyme
for the enediyne core biosynthesis, and introduction of
pBS5020, in which the expression of ncsE is under con-
trol of the constitutive ErmE* promoter, into SB5002 re-
stored NCS production to a level comparable to that of
the wild-type strain as determined by bioassay (Figure
6C) and HPLC analysis (Figure 6D). The identity of NCS
was further confirmed by electrospray ionization-mass
spectrometry (ESI-MS) analysis, and the NCS chromo-
phore showed (M+H)+ ion at m/z = 660.3, consistent
with the molecular formula C35H33NO12. These findings
unambiguously established that NcsE is essential for
NCS biosynthesis, further supporting an iterative type I
PKS paradigm for enediyne core biosynthesis [15–19].
A Convergent Strategy for NCS Assembly
A convergent strategy could be envisaged for the as-
sembly of the NCS chromophore from the three indivi-
dual building blocks of the deoxy aminosugar, naph-
thoic acid, and enediyne core (Figure 3C). While the
coupling between dNDP-sugar and the enediyne core
is catalyzed by the NcsC6 glycosyltransferase, that be-
tween naphthoyl-S-NcsB and the enediyne core is
most likely catalyzed by the NcsB2 CoA ligase. Al-
though the cyclic carbonyl carbon of NCS has pre-Figure 6. Inactivation of ncsE by Gene Replacement
(A) Construction of ncsE gene replacement mutant and restriction
maps of the S. carzinostaticus ATCC15944 wild-type and SB5002
mutant strains showing predicted fragment sizes upon BamHI di-
gestion. B, BamHI.
(B) Southern analysis of wild-type (lane 1) and SB5002 (lanes 2 and
3 are two individual isolates) genomic DNAs digested with BamHI
using ermE as a probe.
(C) Determination of NCS production by assaying its antibacterial
activity against M. luteus. Lane 1, wild-type; Lane 2, SB5002; lane
3, SB5002 complemented by pBS5020 that overexpress ncsE.
(D) HPLC analysis of NCS chromophore (%) isolated from an au-
thentic standard (I), wild-type (II), SB5002 (III), and SB5002 comple-
mented by pBS5020 that overexpresses ncsE.viously been shown to originate from carbonate [12],
no obvious candidate catalyzing the attachment of car-
bonate could be identified within the gene cluster. The
convergent biosynthetic strategy for NCS once again
underscores nature’s efficiency and versatility in syn-
thesizing complex molecules.
Significance
NCS was the first member of the enediyne family of
antitumor antibiotics to be structurally elucidated, yet
cloning and characterization of the NCS biosynthetic
gene cluster has heretofore met with little success in
spite of considerable effort. Early cloning strategies
were based on the general assumption that the bio-
synthesis of the naphthoic acid moiety would be cata-
lyzed by a type II PKS, of the enediyne core by either
a type I or type II PKS, and of the deoxyamino sugar
from dNDP-D-glucose, none of which turned out to be
correct or unique to the NCS pathway. The presence
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tin S. carzinostaticus ATCC15944 also explains why all
qearly attempts in disrupting the NCS pathway yielded
i
ambiguous results. Here we report the cloning and n
confirmation of the NCS biosynthetic gene cluster a
ifrom S. carzinostaticus ATCC15944 and demonstrate
gthe feasibility of manipulating NCS biosynthesis by in
ivivo gene inactivation. Sequence analysis of the
mgenes within the NCS cluster suggested dNDP-D-
t
mannose as a precursor for the deoxy aminosugar, t
revealed two distinct type I polyketide synthases p
w(PKSs), NcsE for the enediyne core and NcsB for the
tnaphthoic acid moiety, and supported a convergent
model for NCS chromophore biosynthesis from the
odeoxy aminosugar, naphthoic acid, and enediyne
t
core building blocks. These findings shed light into b
deoxysugar biosynthesis, further support the itera- m
ative type I PKS paradigm for enediyne core biosynthe-
wsis, and unveil a mechanism for microbial polycyclic
earomatic polyketide biosynthesis by an iterative type
tI PKS. The NCS cluster, together with the growing list
s
of other enediyne biosynthetic gene clusters, provide t
a unique opportunity to investigate the molecular
Pbasis of enediyne biosynthesis by a comparative ge-
3nomics approach and to apply combinatorial bio-
csynthetic methods to the enediyne biosynthetic
cmachinery for anticancer drug discovery and devel-
f
opment. t
Experimental Procedures b
A
Bacterial Strains, Plasmids, and Reagents C
Bacterial strains and plasmids used in this study are summarized T
in Table S1. Biochemicals, chemicals, media, restriction enzymes, p
and other molecular biology reagents were from standard commer- B
cial sources. i
s
DNA Isolation, Manipulation, and Sequencing
DNA isolation and manipulation in E. coli [30] and Streptomyces A
[31] were carried out according to standard methods. For Southern n
analysis, DIG labeling of DNA probes, hybridization, and detection t
were performed according to the protocols provided by the manu- s
facturer (Roche Applied Science, Indianapolis, IN). PCR amplifica- m
tions were carried out on a GeneAmp 2400 thermocycler (Perkin- r
Elmer/ABI, Foster City, CA) using either Vent DNA polymerase (New r
England Biolabs, Beverly, MA) or TaKaRa LA-Taq DNA polymerase S
(Takara Mirus Bio Inc., Madison, WI). For NGDH, the following pair T
of degenerate primers was used: 5#-CS GGS GSS GCS GGS TTC a
ATC GG-3# (forward) and 5#-GG GWR CTG GYR SGG SCC GTA w
GTT G-3# (reverse) (R, A+G; S, C+G; W, A+T; Y, C+T) and for ncsA,
the following pair of primers was used: 5#-G CTT CGG GCG CTT 5
CTC TCA G-3# (forward) and 5#-GCG GAG CGG ATC CTC CGA TC- p
3# (reverse). Primer synthesis and DNA sequencing were performed k
at the Biotechnology Center, University of Wisconsin-Madison. l
m
Genomic Library Construction and Screening T
A genomic library of S. carzinostaticus ATCC15944 was con- t
structed in pOJ446 according to standard protocols [31]. E. coli i
XL1-Blue MRF# and Gigapack III XL packaging extract (Stratagene, (
La Jolla, CA) were used for library construction according to manu- p
facturers’ instructions. The genomic library (4800 colonies) was P
screened by colony hybridization with the PCR-amplified NGDH or m
ncsA fragment as a probe, respectively, and the resultant positive c
clones were further confirmed by Southern hybridization. c
p
Gene Inactivation and Complementation t
We have recently found that S. carzinostaticus ATCC15944 con- f
tains three copies of the NCS biosynthetic gene cluster that are s
cidentical within the sequenced 92 kb DNA region (K.N., J.Z., and.S., unpublished data). This complicates any attempt to disrupt
he NCS pathway since total abolishment of NCS production re-
uires the inactivation of all three copies of the NCS cluster. To
dentify the correct mutant, we screened a large pool of recombi-
ant isolates with the desired antibiotic phenotype by Southern
nalysis. This pool includes mutants with one, two, or all three cop-
es of the NCS cluster disrupted, whose genotypes can be distin-
uished upon Southern analysis. For example, if only one copy is
nactivated, Southern analysis will show a genotype as if it were a
ixture of the expected mutant (the inactivated copy) and the wild-
ype (the other two intact copies). In contrast, if all three copies of
he cluster are inactivated, Southern analysis will yield a distinct
attern such as that shown in Figures 4 and 6. Only the mutants
hose genotypes were confirmed to result from inactivation of all
hree copies of the NCS cluster were selected for further study.
Introduction of plasmid DNA into S. carzinostaticus was carried
ut by polyethylene glycol-(PEG)-mediated protoplast transforma-
ion, following standard procedure [31] with minor modifications. In
rief, mycelia obtained from YEME culture supplemented with 25
M MgCl2 were used to prepare S. carzinostaticus protoplasts,
nd upon mixing with plasmid DNA, the transformed protoplasts
ere spread onto R2YMP (R2YE enriched with 0.5% of Difco malt
xtract and bacto peptone) plates for regeneration. After incuba-
ion at 28°C for 20 hr, the plates were overlaid with soft R2YMP
upplemented with the appropriate antibiotic and incubation con-
inued until colonies appeared (5 to 7 days).
To inactivate orf6, an internal fragment of orf6 was amplified by
CR using the following primers 5#-AGG CGT TGC TGC TTG AG-
#/5#- TGG ACC TGC TGC TCA CC-3#. The PCR product was
loned directly into pGEM-T to yield pBS5025. After sequencing to
onfirm PCR fidelity, a 0.80 bp PstI-BamHI fragment was recovered
rom pBS5025 and cloned into the same sites of pOJ260 to afford
he gene disruption construct pBS5021 (Figure 4A).
To inactivate ncsR1, an internal fragment of ncsR1 was amplified
y PCR using the following pair of 5#-CGG GAT CCC GCT CAC
GC TTC TAC AGC-3#/5#-GGA ATT CCG TCA TTT GAG TGA CGG
-3# (the PCR incorporated BamHI and EcoRI sites are underlined).
he PCR product was directly cloned into pGEM-T to yield
BS5026. After sequencing to confirm PCR fidelity, a 0.96 kb
amHI-EcoRI fragment was recovered from pBS5026 and cloned
nto the same site of pOJ260 to afford the gene disruption con-
truct pBS5022 (Figure 4C).
pBS5021 or pBS5022 was transformed into S. carzinostaticus
TCC15944 by PEG-mediated protoplast transformation, and colo-
ies that were apramycin resistant were identified as gene disrup-
ion mutant strains. Thus, introduction of pBS5021 or pBS5022 re-
ulted in the isolation of the SB5004 (Dorf6) or SB5005 (DncsR1)
utant strains, respectively, in which orf6 or ncsR1 has been dis-
upted by the insertion of the pOJ260 vector into the middle of the
eading frame (Figures 4A and 4C). The genotype of SB5004 and
B5005 was confirmed by Southern analysis (Figures 4B and 4D).
he SB5004 and SB5005 strains were then similarly cultured and
nalyzed for NCS production by bioassay with the ATCC15944
ild-type strain as a control (Figure 4E).
To inactivate ncsE, an 11 kb NdeI fragment (nucleotide no.
1659-62998) that contained the entire ncsE gene, was cloned from
BS5017 into the same sites of pGEM-5Zf to yield pBS5018. A 3.4
b SpeI-NheI fragment and a 4.4 kb MluI-BglII fragment were iso-
ated from pBS5018, and coligated with the 1.8 kb NheI-MluI frag-
ent that contains the erythromycin resistance gene, ermE [31].
he product was digested with XbaI and BamHI and ligated into
he similar sites of pOJ260 to yield pBS5019, in which a 1.2 kb
nternal NheI-MluI fragment of ncsE encoding the AT (partial), ACP
intact), and KR (partial) domains was replaced by ermE (Figure 6A).
BS5019 was introduced into S. carzinostaticus ATCC 15944 by
EG-mediated protoplast transformation. Colonies that were apra-
ycin sensitive and erythromycin resistant were identified as S.
arzinostaticus SB5002 mutant strain, whose genotype was further
onfirmed by Southern analysis (Figure 6B). To make an ncsE ex-
ression construct, a 450 bp EcoRI-BamHI fragment that harbored
he ErmE* promoter from pWHM79 [32] and an 8.9 kb BglII-SpeI
ragment that contained the intact ncsE gene as well as its up-
tream ncsE5 and downstream ncsE10 genes from pBS5017 were
loned into the EcoRI-XbaI sites of pBS3031 [33] to yield pBS5020.
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mediated protoplast transformation to complement the ncsE:ermE
mutation, yielding strain SB5003. Recombinant strains were cul-
tured and analyzed for NCS production by bioassay and/or HPLC
with the S. carzinostaticus wild-type strain as a control (Figures 6C
and 6D).
The PCR-amplified NGDH locus was similarly inactivated, and
the genotype and phenotype of the resultant mutant strain SB5001
(DNGDH) was similarly investigated (Figure S1).
Production, Isolation, and Analysis of NCS
S. carzinostaticus wild-type and recombinant strains were grown
on ISP-2 or R2YMP plates (with appropriate antibiotic for recombi-
nant strains) at 28°C for sporulation [31]. For NCS production, 50
l of spore suspension (cfu >108 cells/ml) of the S. carzinostaticus
ATCC15944 wild-type or recombinant strains was inoculated into
50 ml of seed media (starch 2%, soya flower FT 2%, NaCl 0.5%,
Difco yeast extract 0.5%, CaCO3 0.2%, MnSO4•H2O 0.0005%,
CuSO4•5H2O 0.0005%, and ZnSO4•7H2O 0.0005% [pH 7.2]) in a
250 ml flask and incubated at 28°C and 250 rpm for 2 days. Seed
culture (1 ml) was transferred into 15 ml of production media (4%
glucose, 1.5% Difco casamino acid, MgSO4 1.25%, CaCO3 0.2%,
and K2HPO4 0.1% [pH 7.2]) in a 250 ml flask and incubated at 28°C
and 250 rpm for 2 to 4 days.
For NCS chromophore isolation, the fermentation culture was
centrifuged to remove the mycelia, and the broth, upon adjustment
to pH 3.5 with 1N HCl, was centrifuged again to remove any acid
precipitate. The resultant supernatant was then fractionated by ad-
dition of (NH4)2SO4, and NCS chromoprotein was precipitated be-
tween 40%–85% saturation. The precipitated NCS chromoprotein
was collected by centrifugation, dissolved in 5 volumes of 15 mM
NaOAc (pH 4.5) buffer, and dialyzed against H2O at 4°C. The dia-
lyzed sample was freeze-dried and NCS chromophore was ex-
tracted with MeOH. The isolated yield for the NCS chromophore
from the wild-type strain by this method varies between 1–5 mg/l.
HPLC analysis of NCS chromophore was carried out on a Ca-
denza CD-C18 analytical column (3 , 150 × 4.6 mm, Imtakt Corp.,
Kyoto, Japan). The column was equilibrated with 50% solvent A
(MeOH/HOAc [100:2]) and 50% solvent B (H2O/HOAc [100:2]) and
developed with the following program (0–15 min, 50% A/50%B; 15–
25 min, a linear gradient from 50% A/50%B to 95% A/5%B; 25–30
min, constant 95% A/5%B) at a flow rate of 0.5 ml/min and UV
detection at 320 nm using a Dynamic gradient HPLC system (Rainin
Instruments, Oakland, CA). ESI-MS analysis of NCS was performed
on an Agilent 1000 HPLC-MSD SL instrument (Agilent Technol-
ogies. Palo Alto, CA).
Bioassay of the NCS chromoprotein complex against Micrococ-
cus luteus ATCC9431 was carried out using a paper disc diffusion
method. After removing mycelia from the S. carzinostaticus
ATCC15944 wild-type or recombinant strain culture broth by cen-
trifugation, the resulting supernatant (20 µl) was added to a paper
disc (6 mm I.D.) and placed on a plate containing M. luteus grown
overnight in LB media. Alternatively, agar plugs of S. carzinostati-
cus ATCC15944 wild-type or recombinant strain grown on solid me-
dia were placed directly on M. luteus seeded LB plates. The plate
was incubated at 37°C for 24 hr and NCS chromoprotein concen-
tration was estimated by the size of the growth inhibition zone.
Supplemental Data
Supplemental Data for this article is available online at http://
www.chembiol.com/cgi/content/full/12/3/293/DC1/.
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